Pharmacokinetic Profile of a Low-Molecular Weight Heparin (Reviparin) in Pregnant Patients - A Prospective Cohort Study*

By Crowther M.A.   Spitzer K.   Julian J.   Ginsberg J.   Johnston M.   Crowther R.   Laskin C.  

Thrombosis Research, Vol. 98, Iss. 2, 2000-04 ,pp. : 133-138

Elsevier

Access to resources Recommend Favorite

Low-molecular-weight heparin (reviparin) diminishes tumor cell adhesion and invasion in vitro, and decreases intraperitoneal growth of colonadeno-carcinoma cells in rats after laparoscopy

By Pross M.   Lippert H.   Misselwitz F.   Nestler G.   Kruger S.   Langer H.   Halangk W.   Schulz H.-U.  

Thrombosis Research, Vol. 110, Iss. 4, 2003-06 ,pp. : 215-220

Elsevier

Access to resources Recommend Favorite

VERY LOW DOSES OF UNFRACTIONATED HEPARIN POTENTIATE THE ANTI-Xa ACTIVITY OF LOW MOLECULAR WEIGHT HEPARIN (ENOXAPARIN)

By Perez-Requejo J.L.   Lucena-Solano O.   Perez-Garcia M.   Santarelli M.T.  

Thrombosis Research, Vol. 85, Iss. 3, 1997-02 ,pp. : 259-265

Elsevier

Access to resources Recommend Favorite

Signs of thrombin generation in pediatric cardiac catheterization with unfractionated heparin bolus or subcutaneous low molecular weight heparin for antithrombotic cover

By Roschitz B.   Beitzke A.   Gamillscheg A.   Sudi K.   Koestenberger M.   Leschnik B.   Muntean W.  

Thrombosis Research, Vol. 111, Iss. 6, 2003-01 ,pp. : 335-341

Elsevier

Access to resources Recommend Favorite

Clinical Experiences with Low-Molecular Weight Heparins in Pediatric Patients

By Hofmann S.   Knoefler R.   Lorenz N.   Siegert G.   Wendisch J.   Mueller D.   Taut-Sack H.   Dinger J.   Kabus M.  

Thrombosis Research, Vol. 103, Iss. 5, 2001-09 ,pp. : 345-353

Elsevier

Access to resources Recommend Favorite